Subclonal Driver Mutations Predict Shorter Progression Free Survival in Chronic Lymphocytic Leukemia Following First-Line Chemo(immuno) Therapy: Results from the CLL8 Trial

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image